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Background: Whole genomes, whole exomes and transcriptomes of tumour samples are sequenced routinely to
identify the drivers of cancer. The systematic sequencing and analysis of tumour samples, as well other oncogenomic
experiments, necessitates the tracking of relevant sample information throughout the investigative process. These
meta-data of the sequencing and analysis procedures include information about the samples and projects as well as
the sequencing centres, platforms, data locations, results locations, alignments, analysis specifications and further
information relevant to the experiments.
Results: The current work presents a sample tracking system for oncogenomic studies (Onco-STS) to store these
data and make them easily accessible to the researchers who work with the samples. The system is a web application,
which includes a database and a front-end web page that allows the remote access, submission and updating of the
sample data in the database. The web application development programming framework Grails was used for the
development and implementation of the system.
Conclusions: The resulting Onco-STS solution is efficient, secure and easy to use and is intended to replace the manual
data handling of text records. Onco-STS allows simultaneous remote access to the system making collaboration among
researchers more effective. The system stores both information on the samples in oncogenomic studies and details of
the analyses conducted on the resulting data. Onco-STS is based on open-source software, is easy to develop and can
be modified according to a research group’s needs. Hence it is suitable for laboratories that do not require a
commercial system.
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The field of cancer genomics has been revolutionized by
the development of high throughput sequencing technolo-
gies to survey tumour genomes [1]. Targeted and genome-
scale sequencing and analysis have been conducted on
DNA and RNA from multiple samples to detect aberra-
tions in many tumour types [2-6]. Whole genomes and
exomes are investigated to detect some or all of single nu-
cleotide variations (SNVs), small insertions and deletions
(indels), copy number alteration and structural variation.
Messenger RNA and micro RNA expression are also* Correspondence: Richard.Marais@cruk.manchester.ac.uk
†Equal contributors
1Molecular Oncology Group, University of Manchester, Wilmslow Road,
Manchester M20 4BX, UK
Full list of author information is available at the end of the article
© 2014 Gavrielides et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.analysed to obtain insights in gene expression differences
in tumour cells [3-6].
Recently, large scale cancer genomics projects such as
the International Cancer Genome Consortium (ICGC) [7]
and the Cancer Genome Atlas (TCGA) [8] have been
launched and are already beginning to bear fruit. In
addition, the plummeting cost of next-generation sequen-
cing has allowed smaller sequencing efforts, such as our
own and others, to address questions in cancer genomics
beyond the remit of the larger scale projects [9-13]. How-
ever, even smaller oncogenomic projects can produce data
from different techniques and sequencing platforms that
then undergo a variety of alignment and analysis proce-
dures. Furthermore, more established oncogenomic exper-
iments such as mRNA and DNA microarrays and array
comparative genomic hybridization (aCGH) are oftentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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a sample from a patient may be surveyed by a number of
different technologies within the same laboratory or study.
Molecular biology laboratories need to store relevant in-
formation from the sequencing procedures and analysis to
be able to track an experiment’s progress and specifica-
tions of each sample under study. The data management
and sample tracking systems implemented by larger initia-
tives are often not available to smaller institutes or labora-
tories and information is sometimes stored in manually
managed text or spreadsheet files that render access,
search and management of the data tedious.
A number of Laboratory Information Management Sys-
tems (LIMS) for next generation sequencing experiments
are freely available, including GNomEx [14], openBIS [15],
Galaxy LIMS [16] and SeqBench [17]. However, none of
these systems is designed specifically for oncogenomic
experiments in which both array based and different se-
quencing technologies are used to analyse samples from
tumour, germline, in vitro and xenograft models.
This work presents an open-source and platform inde-
pendent web-based system that facilitates remote storage
and retrieval of next-generation sequencing/oncogenomic
experiment related information. The Sample Tracking
System (Onco-STS) enables users to track DNA and
RNA samples that have been sequenced or analysed in
genomic studies. Onco-STS, which runs on a server, is
accessible remotely by users and includes a database




The system has been developed using the web develop-
ment framework, Grails (http://www.grails.org/). Grails
has a persistence engine built on Hibernate (http://www.
hibernate.org/), and a straightforward Object Relational
Mapping (ORM) that makes it ideal for the rapid devel-
opment of database-backed web applications, since most
database actions can be handled automatically without
any explicit SQL or XML coding on the part of the pro-
grammer. The entire Grails project is wrapped in a war
file with a single command and deployed in an Apache
Tomcat servlet container. The application is easy to
install and takes about 30 minutes. All the necessary files
and instructions to run the application are included in
the supplementary material submitted with this work.
The system is protected by an authentication system and
users must have an account to login to the service in
order to use it. Users may also be granted different au-
thorities according to the different privileges they may
have. As the system is designed for individual laborator-
ies and facilities within a research institute, registered
users have access to the complete database, which meansthat any registered user can see all samples in the data-
base and edit them if they have been assigned editing
privileges. There are three different user account types: a
“read-only” account for users that need only to access
the data but will not be allowed to add new or alter the
existing data, a “write” account for users that will be able
to submit new samples and add new data for the existing
ones and “administrator” account for the administrators
of the system that in addition to updating privileges they
will also be able to manage the users and their accounts.
Onco-STS also has an optional automatic mailing sys-
tem that notifies the users and investigators about sample
and experimental updates. If activated, only users and
investigators associated with the updated sample will be
informed. Mailing settings and user management are
available in the Administration page. The homepage of
Onco-STS is shown in Additional file 1: Figure S1.
Results
Sample tracking data
Data to be submitted to the database include the tumour
or germline sample tissue information, nucleic acid ex-
traction information, the different stages of the oncoge-
nomic experiments that have been conducted on the
samples, the projects that the samples are involved in and
the sources from which the samples have been extracted.
Each sample belongs to a particular project that has a
unique code and name and involves a number of investi-
gators. A project can have multiple samples from the
same or different sources (Additional file 1: Figure S2).
Sample information includes the sample name, the type
of sample (whether it is germline, a primary tumour, a
metastasis, xenograft, cell line or allograft), the site and
histology, surgery information and mouse generation
and number in case of a xenograft/allograft. The meta-
data of the samples include the dates the sample was
submitted to the database, the last time they were al-
tered, the user who created the sample and all the users
who have edited the sample or any other information re-
lated to the sample experiments. Storage information of
the samples under various conditions is also supported
(Additional file 1: Figures S3 & S4). To access samples of
interest users can list all the samples of a project by navi-
gating to the project page or they can use the search form
to search for samples by their main attributes (e.g. name,
type, site, histology, user that submitted the sample). A
quick sample search at the home page is also available.
Information for six oncogenomic high-throughput ex-
periments for each sample are stored in the system:
whole genome sequencing (WGS), whole exome sequen-
cing (WES), RNA sequencing, SNP array, mRNA micro-
array and aCGH (Additional file 1: Figure S4). Any data
files such as FASTQ or BAM files should be saved separ-
ately outside Onco-STS. Onco-STS is designed only for
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actual sequencing and analysis data. Nevertheless, loca-
tion and paths to these data can be saved in the sample
experiment data under “Sequencing Data” section and
“Results Location/Directory” in analysis section, thus
multiple files for the same sample can be tracked.
i. Whole Genome Sequencing;
The whole genome sequencing data include the
genome library, the sequencing process and data -
dates, sequencing centre, platform, number of lanes,
insert and fragment size, location of results etc. –
alignment, analysis and somatic analysis, which
includes used algorithms, duplicates, mapping
information, results locations, dates performed etc.
For the sequencing part quality control information
for each lane can also be stored.
ii. Whole Exome Sequencing;
The tracking data of WES are the same as the WGS
data with additional information for the exome target
capture protocol - manufacturer, kit, date performed
and by whom.
iii. RNA-Seq;
Sequencing of the transcriptome provides information
on gene expression, alternative splicing and gene
fusion transcripts. The tracking data are similar to
Whole Genome Sequencing with differences in
alignment – proportion of reads aligned to introns,
exons and ribosomal RNA.
iv. SNP array;
SNP arrays are conducted for single nucleotide
polymorphisms detection among individuals. Tracking
data include array information, array centre, platform
and array quality control as well as results location
and analysis algorithms used.
v. mRNA microarrays;
Tracking data of mRNA microarrays for mRNA
analysis is largely similar to the SNP array data.
vi. Array-comparative genomic hybridization (aCGH).
aCGH is a method for detection of copy number
alterations in the genome. The data include
Genomic Hybridisation, dates, aCGH centre and
platform, as well as location of results and
algorithms used for analysis.
A comments field is available for all the system
entities (samples, projects, sources and experiments)
to allow any kind of information that is not specified
by the database to be entered.
Sample tracking database schema
Sample table
Onco-STS is a sample driven application. The Sample
table (Figure 1) is connected with a one-to-one (1:1) rela-
tionship to six tables that correspond to the six differentoncogenomic experiments: WGS, WES, SNP, RNA-Seq,
mRNA and aCGH. A one-to-one relationship denotes that
each sample record is linked with foreign keys to one par-
ticular record from each of the experiment tables.
Each sample belongs to a particular source and pro-
ject. Consequently, the Sample table is also connected
with a Source and Project table. The connection to both
tables is through a one-to-many (1:m) relationship, with
“many” on the Sample side, since each project and source
may have multiple different samples (Figure 1).
The users who update the Sample table and any other
table that is directly or indirectly linked to the Sample
table are tracked. To accomplish this the Sample table is
linked with a one-to-many relationship to the User table,
with “many” on the user’s side, denoting that a sample
can be updated by many users (Figure 1). Information
for multiple DNA and RNA extractions for each sample
is included in the Extraction table linked to the Sample
table (Figure 1).
A sample can be linked to an existing primary sample
due to the occurrence of metastases or it can be derived
from a primary sample for experiments involving cell-
lines, allografts and xenografts. To accomplish this inter-
sample relationship the Sample table has a self-referencing
mechanism, which is used to link samples with each other
in a parent–child manner.
Experiments
All six experiment tables directly linked to the Sample
table have exactly the same columns including dates, de-
scription and comments. Each of the experiment tables
is linked to other tables that hold all the information
needed for each experimental record.
i. The WGS table has a 1:1 link to a Sequencing,
Sequencing Data, Library, Alignment, Analysis and
Somatic Analysis table (Additional file 1: Figure S5).
The sequencing procedure can be conducted using
multiple lanes so the Sequencing table has a 1:m link
to a Lane table. The Lane table is 1:1 linked with a
Quality Control (QC) table to store the quality
control information of each lane sequenced.
ii. The WES table is similar to WGS table with
Sequencing, Sequencing Data, Library, Alignment,
Analysis, Somatic Analysis tables, plus an additional
Capture Protocol table. The Lane and QC tables
are also the same as in WGS (Additional file 1:
Figure S6).
iii. The RNA-Seq section is similar to WGS with some
differences in the Alignment and Analysis tables
(Additional file 1: Figure S7).
iv. The SNP array table has 1:1 links to an Array, Data,
and Analysis table. The Array table is connected
with 1:1 relation to a Quality Control table to store
Figure 1 Summary of the database schema with the sample, patient, project and the six experiments tables (WGS, WES, RNASeq, aCGH,
SNPx mRNA) and their connections. The User, Role tables and their connection through the UserRole table are also shown. The Sample table is
connected with one-to-many relationship to the User, Patient and Project tables.
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record (Additional file 1: Figure S8).
v. The mRNA table has 1:1 links to an Array, Data,
and Analysis table. The Array table is connected
with 1:1 relation to a Quality Control table to store
the quality control information for each mRNA
array record (Additional file 1: Figure S9).
vi. The aCGH table has 1:1 links to an Array, Data,
and Genome Hybridization table (Additional file 1:
Figure S10).
The User and Role tables have records of all the users
of the system and the different kind of roles/authorities
granted to them. An entire representation of the data-
base schema is shown in Additional file 1: Figure S11.
Discussion
The sample tracking system developed in this project is
a LIMS for oncogenomics studies and facilitates the
fast, secure storage and retrieval of sample-associatedinformation. Importantly, details of quality control pro-
cedures and analyses of the oncogenomic data are re-
corded in the system in addition to information on the
samples. The web-based service provides advantages
over locally accessed software tools as it is platform in-
dependent and can be accessed even through mobile
devices with a compatible web browser in which case
the user interface will be adjusted to the screen size.
Additionally, minimal system requirements (and no in-
stallation) are needed from the client site and service
updates/bug fixes become immediately available to all
users. As it is a web application that runs on a server it
allows users to access centralized data repositories,
which can make collaborations among distant research
groups more effective. Furthermore, any new data sub-
mitted to the system become instantly available to all
scientific staff with access to the system.
We have designed the system to facilitate its use by
multiple different users. For example, it is envisaged that
new samples could be created by a researcher responsible
Gavrielides et al. Source Code for Biology and Medicine 2014, 9:25 Page 5 of 6
http://www.scfbm.org/content/9/1/25for a project. Subsequently, information about the sequen-
cing process would be added by a technician or core facil-
ity personnel. Thereafter, alignment and analysis tracking
would be completed by a bioinformatician. Hence, the sys-
tem provides a model enabling multiple users to enter
data on specific samples. Each one of the experiment steps
can be marked as completed which will allow users to
check what has been conducted for the experiment and
what follows next. Additionally, the progress of each
experiment is shown with a progress bar on the sample
page to track the progress as it is processed (Additional
file 1: Figure S4). The system’s security prevents any
unauthorized users from accessing or editing the database.
The web application overcomes many of the draw-
backs of having the sample information stored in other
forms such as in text file records and allows quick sub-
mission, editing and querying of the database.
Onco-STS is limited to allow submission of types of
data that have been defined in the system schema. Com-
ments fields in all the system sections provide a facility
for the addition of further information. Importantly, the
system allows linking of samples from the same source
(e.g. primary and metastatic tumours from an individual,
or cell lines and xenografts derived from a tumour). We
have designed the system based on the oncogenomic
studies that we conduct routinely in our laboratory.
Thus the system is not designed to be a comprehensive
resource and is the first version we have constructed.
Further versions will include experiment tables for prote-
omic and epigenomic studies, however these additions are
beyond the scope of the present study.
Although Laboratory Information Management Sys-
tems (LIMS) already exist, many of them are commercial
and not affordable by small research facilities. Addition-
ally, not all of them provide remote and simultaneous
access by multiple users. Whilst large scale projects such
as the ICGC and TCGA will have dedicated sample
tracking solutions, and other research institutes and
large laboratories are likely to have implemented systems,
many of these are likely to be proprietary or commercial
LIMS systems such as the ones offered by Genologics
(http://genologics.com/). Although open-source systems
for next generation sequencing studies have been pub-
lished [14-16], our system is tailored for oncogenomic
experiments from multiple samples from the same or
different sources.
Conclusions
The current work presents a sample tracking system for
oncogenomic studies (Onco-STS) to store these data and
make them easily accessible to the researchers who work
with the samples. Onco-STS is an easily implemented sys-
tem based on open-source software and is amenable tofuture development and modification. Hence it is a good





Operating system: Platform independent.
RAM: 4 GB.
Programming language: Groovy/Grails 2.1.0, Java 1.6.
Other requirements: Grails 2.1.0 installation, Java De-
velopment Kit (JDK) version 1.6 or above, a Java servlet
container like Apache Tomcat, MySQL 5.
Recommended developing tools: Groovy/Grails Tool
Suite IDE.
Service usage requirements: Any operating system
with any modern web browser.
License: GNU GPL3.
Any restrictions to use by non-academics: free to use.
Additional file
Additional file 1: Figure S1. The homepage of Onco-STS. Purple arrows
denote some functional areas of the page. Figure S2. A project record view
with its attributes and all the samples included in it along with their basic
properties. Figure S3. Form for new sample submission. Figure S4. A
sample record view with its properties, links to source and projects it
belongs to, and links the six next generation experiments and their sub-
sections. The ongoing step for each experiment is show on the experiment
progress bar. Figure S5. Whole Genome Sequencing table connected with
the Sequencing, Sequencing Data, Library, Alignment, Analysis, Lane and
Quality Control tables. Figure S6. Whole Exome Sequencing table
connected with the Sequencing, Sequencing Data, Library, Alignment,
Analysis, Capture Protocol, Lane and Quality Control tables. Figure S7. RNA
Sequencing table connected with the Sequencing, Sequencing Data,
Library, Alignment, Analysis, Lane and Quality Control tables. Figure S8.
SNP array table connected with the Array, Data, Analysis and Quality Control
tables. Figure S9. mRNA microarrays Array table connected with the Array,
Data, Analysis and Quality Control tables. Figure S10. Array-Comparative
Genomic Hybridization Array table connected with the Genomic
Hybridization, Data and Analysis tables. Figure S11. The entire database
schema of the Onco-STS.
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